ResearcherOsaka City UniversityNo recent work listed
Shoji Kubo
Matched on ORCID iD 0000-0002-4353-8033; OpenAlex author ID A5049137704, A5081755802. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers
Papers 4
- Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. Co-author DOI 10.1038/s41389-022-00389-4↗
- Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. Last author DOI 10.21873/anticanres.15718↗
- Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.14234↗
- Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Last author PMID 25911890↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenjiro Kimura · 3 shared papers, 2020–2022 · strength 0.35
- Paper Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. DOI 10.21873/anticanres.15718↗
- Paper Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. DOI 10.1038/s41389-022-00389-4↗
- Paper Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal A… DOI 10.21873/anticanres.14234↗
- Hiroji Shinkawa · 3 shared papers, 2015–2022 · strength 0.28
- Paper Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. DOI 10.21873/anticanres.15718↗
- Paper Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal A… DOI 10.21873/anticanres.14234↗
- Paper Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. PMID 25911890↗
- Ryota Tanaka · 2 shared papers, 2020–2022 · strength 0.23
- Paper Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. DOI 10.21873/anticanres.15718↗
- Paper Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal A… DOI 10.21873/anticanres.14234↗
- Ryosuke Amano · 2 shared papers, 2020–2022 · strength 0.23
- Paper Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. DOI 10.21873/anticanres.15718↗
- Paper Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal A… DOI 10.21873/anticanres.14234↗
- Masakazu Yashiro · 2 shared papers, 2020–2022 · strength 0.23
- Paper Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. DOI 10.21873/anticanres.15718↗
- Paper Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal A… DOI 10.21873/anticanres.14234↗
- Kohei Nishio · 1 shared paper, 2022 · strength 0.13
- Shimpei Eguchi · 1 shared paper, 2022 · strength 0.13
- Dinh Viet Hoang · 1 shared paper, 2022 · strength 0.12
- Norifumi Kawada · 1 shared paper, 2022 · strength 0.12
- Sadaaki Yamazoe · 1 shared paper, 2020 · strength 0.09
- Masaichi Ohira · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.